Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Logindo Samudramakmur Tbk. (LEAD) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Logindo Samudramakmur Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Logindo Samudramakmur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 26.5K 24h volume), while Logindo Samudramakmur Tbk. trades at Rp100 (market cap 574.16B, 6.03M 24h volume). The key difference: Logindo Samudramakmur Tbk. is the larger of the two by market cap, and Logindo Samudramakmur Tbk. is more actively traded (6.03M versus 26.5K). Which is the better fit depends on your goals.

DGNSLEAD
Market Cap
308B574.16B
Volume
26.5K6.03M
Lot
26560.3K
Turnover
6.01M596.6M
Average Price
226.6998.94
Value
6.01M596.6M
Indicative Equilibrium Price
230100
Indicative Equilibrium Volume
11046

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
LEAD
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Logindo Samudramakmur Tbk.

PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.

Read more on LEAD